Viz.ai for timely diagnoses
Viz.ai helps care teams react faster with AI-powered healthcare solutions that can detect issues and notify care teams quickly for faster decisions and interventions. Description Viz.ai solutions such as Viz.ai…
SKOUT improves diagnoses and treatment in gastroenterology
SKOUT from Iterative Health uses AI-enabled system to improve disease diagnosis and treatment in gastroenterology. Description The company’s system helps doctors identify potentially cancerous polyps. Their system equally automates the…
Elecsys HIV Duo to screen blood donors
Tradename: Elecsys HIV Duo Proper Name: Elecsys HIV Duo Indication: Intended to screen individual human donors, including volunteer donors of whole blood, blood components and source plasma. The assay is…
Posluma for prostate cancer imaging
Drug Name: Posluma Indications: To use with positron emission tomography imaging in certain patients with prostate cancer. Active Ingredient: Flotufolastat F 18 Company: Blue Earth Diagnostics Ltd. Approval Date: 5/25/2023…
Tempus receives FDA approval for xT CDx, a NGS-Based In Vitro Diagnostic Device
Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s first Premarket Approval (PMA) application for its…
Xenoview for pulmonary imaging
Name: Xenoview Active Ingredient: hyperpolarized Xe-129 Indications: To evaluate pulmonary function and imaging Approval Date: 12/23/2022 Company: Polarean, Inc. Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214375s000lbl.pdf
Elucirem to detect and visualize lesions in the CNS and the body
Drug Approval Name: Elucirem Active Ingredient: gadopiclenol Indications: To detect and visualize lesions, together with MRI, with abnormal vascularity in the central nervous system and the body Approval Date: 9/21/2022…